HSP90AA1 and breast cancer: Indeed, targetable Hsp90 is found in IBC cell lines which are highly susceptible to Hsp90 inhibition25 and therefore, we hypothesized that this clinical BC subtype would be particularly appropriate for HS201-based therapy.